Nifty 50
- Apollo Hospitals₹8,027.50361.50 (4.72%)
- BSE₹3,287.20-47.60 (-1.43%)
- ITC₹26611.00 (4.31%)
- Reliance Industries₹1,170.30-7.70 (-0.65%)
- Eicher Motors₹7,050282.50 (4.17%)
- JSW Steel₹1,168-7.20 (-0.61%)
- TCS₹2,15680.00 (3.85%)
- Cipla₹1,301-5.80 (-0.44%)
- HCL Technologies₹1,216.7039.80 (3.38%)
- Adani Ports₹1,76153.00 (3.10%)
- Infosys₹1,023.4026.40 (2.65%)
- Shriram Finance₹940.4523.20 (2.53%)
- Tata Motors PV₹279.906.90 (2.53%)
- UltraTech Cement₹10,675249.00 (2.39%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Neuland Laboratories Share Price Today
As of 09-10-2026 09:27, Neuland Laboratories Ltd. share price today is ₹0, with a change of ₹-21015.00 (-100.00%) from the previous close of ₹21015. The stock opened at ₹21025 and traded between ₹20790 and ₹21395, with a total traded volume of 24573 shares. The company has a market capitalization of ₹26962 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹24225 and ₹11500, respectively.
Neuland Laboratories Ltd. valuation metrics include a P/E ratio of 54.2, EPS of ₹283.71, and book value of ₹13.30. Profitability indicators show ROE of 19.42% along with a dividend yield of 0.2%. Neuland Laboratories Ltd. has reported revenue of ₹2371.81 Cr and net profit of ₹497.77 Cr.
Neuland Laboratories Ltd. technical indicators include Day RSI at 35.82, Day MFI at 39.27, Day ADX at 28.61. Additional indicators include Commodity Channel Index (CCI) at -103 and Williams %R at -87.2. Momentum indicators show Day MACD at -288, Day MACD Signal Line at -152.41, DayATR at 728.34. Rate of Change indicators for Neuland Laboratories Ltd. include ROC125 at 49.52 and ROC21 at -8.11.
Exponential moving averages include EMA5 at ₹21487, EMA10 at ₹21700.8, EMA12 at ₹21782, EMA20 at ₹22012.9, EMA26 at ₹22070, EMA50 at ₹21698.1, EMA100 at ₹20288.2, EMA200 at ₹18315. Simple moving averages include SMA5 at ₹21591, SMA10 at ₹21591.5, SMA20 at ₹22241, SMA30 at ₹22549.2, SMA50 at ₹22299.4, SMA100 at ₹20071.9, SMA150 at ₹18082.7, SMA200 at ₹17066.2.
Support levels for Neuland Laboratories are placed at First Support ₹20651.67, Second Support ₹20288.33, Third Support ₹19651.67. Resistance levels are seen at First Resistance ₹21651.67, Second Resistance ₹22288.33, Third Resistance ₹22651.67. Neuland Laboratories Ltd. shareholding pattern shows promoter holding at 32.62%, FII holding at 21.08%, DII holding at 0%, public holding at 29.79%.
Neuland Laboratories Performance
Price Movement
₹20790.00
₹21395.00
1 Year Performance
₹11500.00
₹24225.00
Markets Today
Historical Performance
Neuland Laboratories Fundamentals
Neuland Laboratories Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 641.58 | 776.25 | 439.71 | 514.27 | 292.75 |
| Operating Expense | 419 | 469.35 | 362.78 | 359.15 | 258.46 |
| Operating Profit | 222.58 | 306.90 | 76.93 | 155.12 | 34.29 |
| Depreciation | 26.56 | 25.09 | 23.92 | 22.54 | 20.19 |
| Interest | 6.97 | 7.23 | 6.79 | 5.34 | 4.58 |
| Tax | 50.17 | 74.52 | 13.86 | 32.58 | 3.67 |
| Net Profit | 147.36 | 212.52 | 40.42 | 96.46 | 13.71 |
Neuland Laboratories Technicals
Neuland Laboratories Ltd. EMA & SMA
₹20830.00
↗ Bullish Moving Average
5
↘ Bearish Moving Average
11
Neuland Laboratories Support and Resistance
Resistance
Support
Technical Indicators
Neuland Laboratories Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 32.7 | 32.7 | 32.6 | 32.6 | 32.6 | 32.6 |
| FII | 22.1 | 21.7 | 20.6 | 20.9 | 20.5 | 21.1 |
| DII | 11.4 | 12 | 14 | 14.7 | 15.8 | 16.5 |
| Public | 33.8 | 33.7 | 32.8 | 31.8 | 31.1 | 29.8 |
Neuland Laboratories Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 13.09 K | 31.3 K | 41.80% |
| Week | 29.78 K | 56.6 K | 52.61% |
| 1 Month | 29.15 K | 55.34 K | 52.67% |
| 6 Month | 26.47 K | 65.66 K | 40.32% |
Neuland Laboratories SWOT Analysis
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Companies with high TTM EPS Growth
Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Insiders bought stocks
Stocks Outperforming their Industry Price Change in the Quarter
Neuland Laboratories Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 24 Jul, 2026 | 34 | FINAL | 24 Jul, 2026 | Equity Share |
| 18 Jul, 2025 | 12 | FINAL | 18 Jul, 2025 | Equity Share |
| 12 Jul, 2024 | 14 | FINAL | Equity Share | |
| 11 Jul, 2023 | 10 | FINAL | Equity Share | |
| 14 Jul, 2022 | 5 | FINAL | 15 Jul, 2022 | Equity Share |
| 29 Jun, 2021 | 3 | FINAL | Equity Share | |
| 10 Nov, 2020 | 2 | INTERIM | 11 Nov, 2020 | Equity Share |
| 18 Feb, 2020 | 2 | INTERIM | 20 Feb, 2020 | Equity Share |
| 27 Jun, 2019 | 1.2 | FINAL | Equity Share | |
| 04 Aug, 2016 | 2 | FINAL | Equity Share |
Neuland Laboratories Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,550 | ₹865.90 | ₹1,490.30 | ₹1,835 | ₹2,368.50 | ₹197.15 |
| % Change | 0.95% | -0.76% | -1.02% | -0.89% | -0.48% | 0.37% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 88.20 | 85.30 | 88.40 | 34.70 | 48.10 | -83.40 |
| 1 Year Return | 216.58 | 13.13 | 75.99 | 34 | -3.05 | 1.36 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Similar Stocks
ACUTAAS
Acutaas Chemicals Ltd.
₹ 3160.10
+3.38%
GLAND
Gland Pharma Ltd.
₹ 3058.00
-0.69%
LAURUSLABS
Laurus Labs Ltd.
₹ 2036.60
+1.94%
ALKEM
Alkem Laboratories Ltd.
₹ 5279.00
+0.56%
BIOCON
Biocon Ltd.
₹ 349.40
-0.17%
DIVISLAB
Divi's Laboratories Ltd.
₹ 9340.00
-0.22%
GRANULES
Granules India Ltd.
₹ 814.00
-0.13%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 3405.00
-0.89%
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹ 1117.50
+0.49%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2293.00
+4.60%
WOCKPHARMA
Wockhardt Ltd.
₹ 2001.00
-1.41%
SHILPAMED
Shilpa Medicare Ltd.
₹ 1025.60
+0.03%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1693.00
+2.92%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1760.00
+0.01%
IPCALAB
Ipca Laboratories Ltd.
₹ 1912.00
-1.36%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2532.10
-0.09%
ABBOTINDIA
Abbott India Ltd.
₹ 25950.00
+1.45%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4656.90
+0.86%
LUPIN
Lupin Ltd.
₹ 1956.50
+1.01%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1197.00
+1.44%
CIPLA
Cipla Ltd.
₹ 1301.00
-0.44%
FAQ's on NEULANDLAB
What is the current share price of Neuland Laboratories Ltd.?
What is the Market Capitalization of Neuland Laboratories Ltd.?
What are the PE and PB ratios for Neuland Laboratories Ltd.?
What is the 52-Week High and Low for Neuland Laboratories Ltd.?
What is the current dividend yield for Neuland Laboratories Ltd.?
Who are the major shareholders of Neuland Laboratories Ltd.?
Who are the peers of Neuland Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Neuland Laboratories Ltd.?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy